These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. ONCOLYSIS BY CLOSTRIDIA. IV. EFFECT OF NONPATHOGENIC CLOSTRIDIAL SPORES IN NORMAL AND PATHOLOGICAL TISSUES. THIELE EH; ARISON RN; BOXER GE Cancer Res; 1964 Feb; 24():234-8. PubMed ID: 14115689 [No Abstract] [Full Text] [Related]
47. Some observations on the quality control testing of Clostridium chauvoei vaccines. Chandler HM Dev Biol Stand; 1976; 32():137-41. PubMed ID: 1001827 [TBL] [Abstract][Full Text] [Related]
48. Cytotoxicity and reduction of animal cell growth by Clostridium M-55 spores and their extracts. Chagnon A; Hudon C; McSween G; Vinet G; Fredette V Cancer; 1972 Feb; 29(2):431-4. PubMed ID: 4622423 [No Abstract] [Full Text] [Related]
49. Apertures in the Clostridium sporogenes spore coat and exosporium align to facilitate emergence of the vegetative cell. Brunt J; Cross KL; Peck MW Food Microbiol; 2015 Oct; 51():45-50. PubMed ID: 26187826 [TBL] [Abstract][Full Text] [Related]
50. Characteristics and immunizing properties of culture filtrates of Clostridium chauvoei. Claus KD; Macheak ME Am J Vet Res; 1972 May; 33(5):1031-8. PubMed ID: 5023040 [No Abstract] [Full Text] [Related]
51. Alteration of the immune reactions by whole-body and local microwave hyperthermia in normal and tumour-bearing animals: review of own 1976-1980 experiments. Janiak M; Szmigielski S Br J Cancer Suppl; 1982 Mar; 5():122-6. PubMed ID: 7039650 [No Abstract] [Full Text] [Related]
52. High-pressure destruction kinetics of Clostridium sporogenes spores in ground beef at elevated temperatures. Zhu S; Naim F; Marcotte M; Ramaswamy H; Shao Y Int J Food Microbiol; 2008 Aug; 126(1-2):86-92. PubMed ID: 18593644 [TBL] [Abstract][Full Text] [Related]
53. Functional antibodies produced by oncolytic clostridia. Groot AJ; Mengesha A; van der Wall E; van Diest PJ; Theys J; Vooijs M Biochem Biophys Res Commun; 2007 Dec; 364(4):985-9. PubMed ID: 17971292 [TBL] [Abstract][Full Text] [Related]
54. The protective antigen of a highly immunogenic strain of clostridium chauvoei including an evaluation of its flagella as a protective antigen. Chandler HM; Gulasekharam J J Gen Microbiol; 1974 Sep; 84(1):128-34. PubMed ID: 4436640 [No Abstract] [Full Text] [Related]
55. [The differentiation of clostridial microcultures on nuclepore-filters by fluorescent antibodies as a rapid screening test for spores. II. Application of fluorescent antibodies (author's transl)]. Koch K; Böhm R; Strauch D Zentralbl Bakteriol Orig A; 1978 Oct; 241(4):463-72. PubMed ID: 366996 [TBL] [Abstract][Full Text] [Related]
56. [The tumor-tetanus assay--experimental studies on the biological differentiation between carcinogenesis and organ regeneration of the rat (author's transl)]. Schneeweiss U; Fabricius EA Arch Geschwulstforsch; 1975; 45(1):3-15. PubMed ID: 168834 [TBL] [Abstract][Full Text] [Related]
57. Effects of inoculum level and pressure pulse on the inactivation of Clostridium sporogenes spores by pressure-assisted thermal processing. Ahn J; Balasubramaniam VM J Microbiol Biotechnol; 2007 Apr; 17(4):616-23. PubMed ID: 18051273 [TBL] [Abstract][Full Text] [Related]
58. [Trials of immunostimulation of an antitoxic response with levamisole in the immunization of sheep with a combined clostridial vaccine]. Bineva I; Peĭchev B; Marinov MI Vet Med Nauki; 1986; 23(4):35-8. PubMed ID: 2874649 [TBL] [Abstract][Full Text] [Related]
59. Localized hyperthermia in the treatment of cancer. Storm FK; Morton DL Nihon Gan Chiryo Gakkai Shi; 1982 Feb; 17(1):75-106. PubMed ID: 7130788 [No Abstract] [Full Text] [Related]
60. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation. Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]